MedPath

Nutrition and Exercise Study to Understand Metabolic Syndrome

Phase 2
Completed
Conditions
Obesity
Insulin Resistance
Metabolic Syndrome
Interventions
Behavioral: Health education
Behavioral: Yoga
Registration Number
NCT02899910
Lead Sponsor
Vanderbilt University Medical Center
Brief Summary

The purpose of this study is to measure the metabolic and behavioral effects of a 12-week yoga program coupled to health education (HED) compared to HED alone.

Detailed Description

The purpose of this study is to measure the metabolic and behavioral effects of a 12-week yoga program coupled to health education (HED) compared to HED alone. In a randomized clinical trial of 90 patients (45 patients per arm), investigators will measure the effects of the two interventions on IR, HTN, dysplidemia, and body composition (See Figure 1. Study Diagram). Subjects will be scheduled for outcome assessment at baseline, 12 weeks, and 24 weeks. In addition, investigators will collect data at baseline and 12 weeks on self-efficacy, stress, mindfulness, and mood. As a sub-study to the randomized controlled trial, investigators will measure the aerobic intensity of the yoga to estimate the dose of physical exercise provided by the yoga (n=10).

Subjects willing and eligible to participate in the RCT will receive written consent. Consented subjects will be randomized to either 12 weeks of yoga with HED versus HED alone. Subjects randomized to yoga will receive 30 to 45 minutes of weekly yoga instruction, followed by 30 to 45 minutes of HED. Subjects will receive written instructions for home yoga practice and lifestyle changes based on HED. Subjects randomized to HED alone will receive a weekly standardized HED curriculum which will be attention and time matched to the yoga with HED arm.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
67
Inclusion Criteria
  • Elevated waist circumference (Men greater than 102cm; women greater than 88cm)
  • Impaired fasting glucose (100-125 mg/dl)
  • Elevated blood pressure (systolic ≥130 and/or diastolic ≥ 85)
  • Dyslipidemia (triglycerides ≥150 and/or HDL≤ 40 for men; 50 for women)
  • Age ≥ 18
  • English speaking
Exclusion Criteria
  • Currently taking blood pressure medications, oral diabetic medication or insulin, or lipid medication
  • Systolic blood pressure ≥160 and/or diastolic ≥100
  • Unstable cardiac disease e.g. angina, life threatening arrhythmia
  • Lung disease requiring oxygen supplementation at rest or with ambulation
  • History of dementia or cognitive impairment
  • Uncontrolled psychiatric disorders, such as major depression or psychosis
  • Current participation in a mind-body practice/program

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Yoga with health educationYoga12 week yoga program coupled to standardized health education for weight loss
Yoga with health educationHealth education12 week yoga program coupled to standardized health education for weight loss
Health educationHealth educationStandardized health education for weight loss
Primary Outcome Measures
NameTimeMethod
Change in insulin resistanceBaseline, 12 weeks, and 24 weeks
Secondary Outcome Measures
NameTimeMethod
Change in affect measured through questionnaire Profile of Mood StatesBaseline and 12 weeks

Profile of Mood States

Change in hypertensionBaseline, 12, and 24 weeks

Blood pressure

Change in stressBaseline and 12 weeks

Perceived Stress Scale-10

Change in mindfulnessBaseline and 12 weeks

Mindful Attention and Awareness Scale

Change in dietBaseline, 12, and 24 weeks

Dietary intake assessed with Block Brief 200 Food Frequency

Change in dyslipidemiaBaseline, 12, and 24 weeks

Fasting lipids

Change in body compositionBaseline, 12, and 24 weeks

Waist circumference and bioelectrical impedance

Change in physical activity measured with accelerometersBaseline, 12, and 24 weeks

Assessed with accelerometers

Change in self-efficacyBaseline and 12 weeks

Perceived Health Competence Scale

Change in quality of lifeBaseline and 12 weeks

SF-36

© Copyright 2025. All Rights Reserved by MedPath